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Hepato biliary diseases are the serious 
ailments affecting population worldwide. 
Hepatobiliary disease includes a 
heterogeneous group of diseases of the 
liver and biliary system caused by viral, 
bacterial, and parasitic infections, alcohol 
consumption, poor nutrition, and 
metabolic disorders. The liver is a well-
known organ for Ayurveda. In Vedas, liver 
is mentioned by “Yakna” word. (1) 
Yakritword id derived from Sanskrit word 
Yat i.e., conversion and Krit means to do. 
Yakrit is regarded as a main organ that 
executes all key metabolic tasks, and its 
disruption can result in a variety of Yakrit 
vikaras. Yakrit functions are altered when 
Pitta Prakopa nidanas are used frequently 
and excessively. Yakrit vikaras (liver 
disorders) are fully explained in various 
Samhitas. 
Liver is the largest gland in the body, 
performing metabolism of all the 
nutritional substances. It is the commonest 
site for accumulation of fat because it 
plays central role in fat metabolism. (2) 
Fatty alteration might be moderate and 
reversible, or severe and cause irreversible 
cell harm and death, depending on the 
source and quantity of build-up. Fatty 
Liver is caused by disturbances in lipid 
metabolism in the liver caused by a variety 
of etiological causes. Fatty liver is a 
reversible disorder in which a big quantity 
of fat builds up in the liver cells due to 
steatosis. Fatty liver is a condition that 
occurs when the fat content of the liver 
surpasses 5% of the total weight of the 
liver or when more than 30% of the 
hepatic cells in a liver lobule have fat 
deposits. (3)
 
In Ayurveda, Yakrit dalludara refers to 
an increase in the size of the liver (Yakrit 
vridhi). Kaphaja Yakrit dalludara occurs 
when Kapha dosha increases, resulting in 
a rise in the size of the liver. The Meda 
inside the Yakrit is then increased, 
resulting in Medaja Yakrit dalludara. (41) 
NAFLD (non-alcoholic fatty liver disease), 
also known as hepatic steatosis and 
Kaphaja yakrit dalludara in Ayurveda, is 
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characterised by fat deposition in the liver 
in the absence of heavy alcohol 
consumption. It is a worldwide public 
health problem caused by dietary hyper 
nutrition, which leads to obesity and type 
II diabetes, and is linked to smoking, 
hypertension, and dyslipidaemia. Non-
alcoholic fatty liver disease is an umbrella 
term for a histological spectrum ranging 
from simple steatosis, defined as a 
concentration of hepatic triglycerides 
greater than five percent of liver weight. 
The aetiology of fatty liver is divided into 
two types as mentioned in figure 1. The 
first group includes circumstances in 
which there is an excess of fat on the body, 
putting additional strain on the liver's 
ability to metabolise fat. The second group 
includes liver cell damage, in which fat 
cannot be digested owing to harm to the 
liver cells. 
The prevalence of Non-alcoholic fatty 
liver disease is 9-40% in Asia. Recent 
studies from the Indian subcontinent 
recorded a prevalence of 9-32% in the 
general population4. Insulin resistance, 
poor glycaemic control, and altered lipid 
metabolism have all been proposed as 






Figure 1. Etiology of fatty liver 
Etio-pathogenesis 
The Ranjaka pitta, which turns Apya 
Rasa Dhatu into Rakta Dhatu, is based in 
Yakrit. It is also associated to Raktavahi 
and Mamsavahi Dhamani and is the 
Mulasthana (place of origin) of 
Raktavahasrotas. Yakrit is a significant 
Koshthanga that is closely linked to the 
Rasa, Rakta, and Mamsa Dhatus and plays 
a significant part in the Dhatu Parinama. 
(6) The key etiological causes of fatty liver 
include a high-fat diet, junk food, soft 
drinks, sedentary lifestyle, metabolic 
syndrome (obesity, diabetes mellitus, 
dyslipidemia), medicines (corticosteroids, 
tetracyclin), etc. Figure 1 illustrates the 
aetiology of fatty liver disease. The Dushti 
of Annavaha, Udakavaha, Rasavaha, 
Raktavaha, Medovaha, etc. is caused by a 
high-fat diet, soft beverages, and a 
sedentary lifestyle, according to Ayurvedic 
theory. Nidanarthakara Rogas are Ajirna 
(indigestion), Sthaulya (obesity), and 
Prameha (diabetes mellitus) that result 
Conditions with excess fat 
• Diabetes mellitus 
• Obesity 
• Hyperlipidaemia 
Liver cell damage 
• Alcoholic Liver Disease 
• Starvation 
• Protein calorie malnutrition 
• Chronic illness (e.g. TB) 
• Acute fatty liver in late pregnancy 
• Hypoxia ( Anemia, cardiac failure) 
• Hepatotoxins (Carbon 
tetrachloride, chloroform) 
• Drug induced liver cell injury 
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from the vitiation of the Annavaha, 




Fatty liver disease like Sthaulya, is a 
Santarpanajanya Vyadhi (disease caused 
by overeating) with Nidana (aetiology) 
and Samprapti (pathogenesis). Agnivikruti 
(Vitiation of the digestive system) causes 
the creation of Apakva Anna Rasa 
(Improperly produced digestive end 
product), which causes the vitiation of 
Kaphadosha and uneven formation and 
deposit of Meda (fat tissue) in Yakrit. Fatty 
Liver is the medical term for this ailment. 
Srotorodha (channel obstruction) is caused 
by vitiated Kapha and Meda, which 
promotes Vata. Agnivikruti is caused by 
vitiated Vata, and the cycle repeats. 
Hepatocytes undergo inflammatory 
alterations when Pitta is implicated in the 
pathophysiology, and the illness develops 
to the next stage, NASH. When Vata 
enters the picture, fibrosis develops, and 
the condition may advance to its extremes.  
Hepatocytes experience inflammatory 
alterations when Pitta is implicated in the 
pathophysiology, and the illness develops 
to the next stage. When Vata enters the 
picture, fibrosis develops, which can lead 
to cirrhosis, ascites, and hepatocellular 
carcinoma, as well as other metabolic 
problems. Vitiation of Samanavayu, 
Apanavayu, Pachakapitta, Ranjakapitta, 
Kledaka kapha, Rasa Rakta Medo dhatu, 
and Pureesha are major variables involved 
in the etiopathogenesis of fatty liver.
 
(8) 
Srotas associated in the aetiology and 
expression of fatty liver are Annavaha, 
Udakavaha, Rasavaha, Raktavaha, 
Medovaha, and Pureeshavaha. 
Predisposing factors  
 Type 2 diabetes and prediabetes 
 Obesity 
 Middle aged or older (although 
children can also get it) 
 High levels of fats in the blood, such 
as cholesterol and triglycerides 
 High blood pressure 
 Certain drugs, such as corticosteroids 
and some cancer drugs 
 Certain metabolic disorders, 
including metabolic syndrome 
 Rapid weight loss 
Clinical sign and symptoms 
Patients with fatty liver disease 
manifest with abdominal heaviness and 
distention, increased or reduced hunger, 
constipation or diarrhoea, lethargy, and 
burp in the early stages. This situation is 
certainly comparable to Ajirna.
 
(9) The 
presentation in obese people is quite 
similar to that of Sthaulya. When fatty 
liver progresses to the next stage, which 
resembles to Amlapitta (Gastro-
eosophageal Reflex Disease), in which 
patients experience sour eructation, chest 
and abdominal burning, abdominal 
distention, tastelessness, and loose stools. 
Systemic characteristics suggestive of 
more significant liver illnesses such as 
Pandu (Anemia, Fatigue, Altered 
Sensorium) (10), Kamala (yellowish 
sclera, skin, and urine), and Raktapitta 
(haematemesis) will become increasingly 
visible as the condition develops to 
Fibrosis and Cirrhosis. Finally, it 
manifests as one of the Ashtamahagada's 
eight primary ailments, namely Udara 
(Ascites); Yakriddalyudara is more 
prominent 
Management 
Dietary restriction, physical exercise 
and weight reduction form the first line of 
treatment. There is need of alternative 
treatment modalities which are safe and 
cost-effective. Ayurveda has immense 
potential in the management of fatty liver 
disease. Things to keep in mind while 
treating fatty liver are Agnivikruti, vitiation 
of Kapha and Meda at the Mula Sthana of 
Raktavaha Srotasa, Srotorodha and 
vitiation of Vata. Agnideepana 
(stimulation of digestive fire), Rookshana 
(dryness therapy), Srotosodhana (removal 
of blockage of channels), pacification of 
Kapha, Meda and Vata should be the first 
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line of treatment in the management of 
Fatty Liver. Here, the treatment principle 
adopted is almost similar to that of 
Sthaulya. (11) When the fatty liver reaches 
the next stage and the Dhatus get engaged, 
therapy should focus on the purification of 
Rasa and Rakta, as well as 
Yakritshothahara (relieves hepatic 
inflammation). 
.  
Figure 2. Some symptoms of Fatty liver disease 
The careful use of the four treatment 
limbs, namely Samsodhana, Samshamana, 
Ahara, would aid in the reversal of fatty 
liver abnormalities and the avoidance of 
additional problems. In cases of liver 
problems, Virechana is the best Shodhana 
Karma. After undergoing Virechana 
therapy, patient experiences lightness in 
the body and improves the appetite. It is 
helpful in elimination excessive Pitta 
dosha alongwith Vata and Kapha 
dosha.Excessive Dosha buildup and 
Srotorodha are both indications. It has the 
properties of Agnideepana and 
Srotoshodhana. For this reason, a variety 
of Churna, Taila, Ghrita, and 
Avalehaconcoctions listed in classical 
writings and accessible in marketplaces are 
commonly employed. Patoladi, 
Hapushadi, etc. Patoladi, Hapushadi, 
Narayana, Avipatti, Erandataila, Trivrit 
Avaleha, Misraka sneha, and Haritakyadi 
ghrita are some of the Churnas that may 
be employed for this purpose. (12)
 
Vamana procedure is also helpful in 
reducing weight, total cholesterol levels 
and triglyceride levels. This therapy 
improves liver function by reducing the 
urea levels and serum creatinine levels. 
Single herbs like Sharapunkha, 
Bhoomiamalaki, Katuki, Guduchi, 
Haritaki, Vasa, and Pippali can be utilised 
safely in Shamana chikitsa for the 
successful control. All of these 
medications shown hepato-protective 
property. Kashaya (Vasaguduchyadi, 
Phalatrikadi, Drakshadi, Patola 
Katurohinyadi), Arishta 
(Sudarshanaarishta, Rohitakarishta, 
Pippalyasava), Churna (Hinguvachadi, 
Vaiswanara), etc. 
Conclusion 
Alteration in the human-environment 
interaction is a key cause of all illnesses, 
including metabolic syndrome, which is 
mostly caused by poor nutrition and 
lifestyle choices. Fatty liver disease is an 
increasing condition that may progress to 
end stage liver disease. It has potential to 
progress to cirrhosis and liver failure. No 
established pharmacological treatment is 
available for fatty liver disease in modern 
medicine. Its treatment is still evolving, 
with no single drug clearly shown to be 
effective. Hence, there is a search for 
alternative treatment modalities in other 
systems of medicine, which is safe and 
cost-effective. As a result, nutrition and 
lifestyle have a significant role in the 
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development, prevention, and treatment of 
fatty liver disease. The diet should be 
changed according to Acharya Charaka's 
"Eight Rules of Eating." Yoga and 
Pranayama may be incorporated into one's 
everyday practise to improve outcomes. 
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